CA2537955A1 - Diagnostic marker for ovarian cancer - Google Patents
Diagnostic marker for ovarian cancer Download PDFInfo
- Publication number
- CA2537955A1 CA2537955A1 CA002537955A CA2537955A CA2537955A1 CA 2537955 A1 CA2537955 A1 CA 2537955A1 CA 002537955 A CA002537955 A CA 002537955A CA 2537955 A CA2537955 A CA 2537955A CA 2537955 A1 CA2537955 A1 CA 2537955A1
- Authority
- CA
- Canada
- Prior art keywords
- haptoglobin
- precursor
- ovarian cancer
- antibody
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003904844 | 2003-09-05 | ||
| AU2003904844A AU2003904844A0 (en) | 2003-09-05 | Diagnostic marker | |
| PCT/AU2004/001205 WO2005024054A1 (en) | 2003-09-05 | 2004-09-06 | Diagnostic marker for ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2537955A1 true CA2537955A1 (en) | 2005-03-17 |
Family
ID=34230078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002537955A Abandoned CA2537955A1 (en) | 2003-09-05 | 2004-09-06 | Diagnostic marker for ovarian cancer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070053896A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1668149A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007504463A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1871362A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2537955A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005024054A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114324557A (zh) * | 2021-12-03 | 2022-04-12 | 融智生物科技(青岛)有限公司 | 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法 |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
| US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
| US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
| CN101243319B (zh) * | 2005-06-22 | 2016-01-06 | 约翰·霍普金斯大学 | 卵巢癌的生物标记:ctap3-相关蛋白质 |
| US8249814B2 (en) | 2005-10-21 | 2012-08-21 | Genenews Inc. | Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject |
| WO2007081385A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| JP2009524438A (ja) * | 2006-01-27 | 2009-07-02 | トライパス イメージング インコーポレイテッド | 卵巣癌を有する可能性の高い患者を同定するための方法およびそのための組成物 |
| WO2007133710A2 (en) | 2006-05-11 | 2007-11-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use thereof |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| SG140505A1 (en) * | 2006-09-05 | 2008-03-28 | Univ Singapore | Diagnostic biomolecule(s) |
| WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| JP5422785B2 (ja) * | 2008-09-12 | 2014-02-19 | 国立大学法人名古屋大学 | 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー |
| WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| GB0917044D0 (en) * | 2009-09-29 | 2009-11-18 | Cytoguide As | Agents, uses and methods |
| US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
| EP4435111A1 (en) | 2010-02-12 | 2024-09-25 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| WO2011143292A1 (en) * | 2010-05-11 | 2011-11-17 | Ohio University | Biomarkers for detecting erythropoietin use in human subjects |
| KR101313184B1 (ko) * | 2010-06-24 | 2013-09-30 | 한국표준과학연구원 | 질병 지표 검출 키트 및 질병 지표 검출 방법 |
| WO2012045012A2 (en) | 2010-09-30 | 2012-04-05 | Raindance Technologies, Inc. | Sandwich assays in droplets |
| EP3859011A1 (en) | 2011-02-11 | 2021-08-04 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
| WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
| EP2714970B1 (en) | 2011-06-02 | 2017-04-19 | Raindance Technologies, Inc. | Enzyme quantification |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| WO2012174569A2 (en) * | 2011-06-17 | 2012-12-20 | The Board Of Trustees Of The University Of Arkansas | New markers for early diagnosis of ovarian cancer, monitoring during therapy, and new therapy options during and after chematherapy |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US20130210659A1 (en) | 2012-02-10 | 2013-08-15 | Andrew Watson | Molecular diagnostic screening assay |
| WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
| EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| CN104225619B (zh) * | 2013-06-09 | 2018-04-17 | 上海吉凯基因化学技术有限公司 | 人ilk基因治疗肿瘤的用途及其相关药物 |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
| KR101582416B1 (ko) * | 2014-06-30 | 2016-01-06 | 가톨릭대학교 산학협력단 | 프로합토글로빈을 이용한 간암 진단방법 |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| CN108884457A (zh) * | 2016-03-29 | 2018-11-23 | 协和发酵麒麟株式会社 | 以在血中与触珠蛋白结合而形成多价免疫复合物的抗体作为有效成分的自身免疫性疾病治疗剂 |
| CN106520924A (zh) * | 2016-10-14 | 2017-03-22 | 浙江大学 | 一种用于检测卵巢癌的引物组及检测方法 |
| CN106544421B (zh) * | 2016-10-21 | 2020-05-08 | 武汉科技大学 | Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途 |
| US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946774A (en) * | 1987-11-09 | 1990-08-07 | Trustees Of Boston University | Process for detecting cancer and for monitoring the effectiveness of cancer therapy |
| EP0454782B1 (en) * | 1989-01-17 | 1997-04-16 | The Johns Hopkins University | Cancer related haptoglobin (hpr) |
| GB9805477D0 (en) * | 1998-03-13 | 1998-05-13 | Oxford Glycosciences Limited | Methods and compositions for diagnosis of rheumatoid arthritis |
| US7112408B2 (en) * | 2001-06-08 | 2006-09-26 | The Brigham And Women's Hospital, Inc. | Detection of ovarian cancer based upon alpha-haptoglobin levels |
| AU2002335963A1 (en) * | 2001-11-23 | 2003-06-10 | Syn.X Pharma, Inc. | Protein biopolymer markers predictive of alzheimers disease |
| AU2003235749A1 (en) * | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
-
2004
- 2004-09-06 JP JP2006525571A patent/JP2007504463A/ja active Pending
- 2004-09-06 US US10/570,751 patent/US20070053896A1/en not_active Abandoned
- 2004-09-06 WO PCT/AU2004/001205 patent/WO2005024054A1/en not_active Ceased
- 2004-09-06 CN CNA200480030838XA patent/CN1871362A/zh active Pending
- 2004-09-06 CA CA002537955A patent/CA2537955A1/en not_active Abandoned
- 2004-09-06 EP EP04761242A patent/EP1668149A4/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114324557A (zh) * | 2021-12-03 | 2022-04-12 | 融智生物科技(青岛)有限公司 | 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法 |
| CN114324557B (zh) * | 2021-12-03 | 2024-05-10 | 融智生物科技(青岛)有限公司 | 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1668149A4 (en) | 2007-01-03 |
| EP1668149A1 (en) | 2006-06-14 |
| US20070053896A1 (en) | 2007-03-08 |
| JP2007504463A (ja) | 2007-03-01 |
| CN1871362A (zh) | 2006-11-29 |
| WO2005024054A1 (en) | 2005-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070053896A1 (en) | Diagnostic marker for ovarian cancer | |
| Ahmed et al. | Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer | |
| Ye et al. | Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine | |
| US20090209431A1 (en) | Non-Invasive in Vitro Method to Detect Transitional Cell Carcinoma of the Bladder | |
| US20190285637A1 (en) | Biomarkers for gastric cancer and uses thereof | |
| EP2375254A1 (en) | Free NGAL as a biomarker for cancer | |
| Yang et al. | Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases | |
| WO2011035433A1 (en) | Selected strains on serum-free growth media for proteomics analysis of lung cancer biomarkers | |
| Yamashita et al. | Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression | |
| US20140274794A1 (en) | Methods and Compositions for Diagnosis of Ovarian Cancer | |
| CA2453580A1 (en) | Detection of ovarian cancer based upon alpha-haptoglobin levels | |
| WO2009039023A2 (en) | Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast | |
| US20100216654A1 (en) | Biomarkers of prostate cancer and uses thereof | |
| WO2010015659A1 (en) | Cancer markers and methods for their detection | |
| US8642347B2 (en) | Urinary CA125 peptides as biomarkers of ovarian cancer | |
| EP3092495B1 (en) | Srm assay for pd-l1 | |
| Gibson et al. | Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis | |
| Chahed et al. | Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis | |
| KR102402428B1 (ko) | 난소암 진단용 다중 바이오 마커 및 이의 용도 | |
| Zhang et al. | Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma | |
| Zhang et al. | Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker | |
| Peng et al. | A rat‐to‐human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis | |
| CN114791492B (zh) | Cst1联合gpx4作为胃癌转移标志物或预后标志物的应用 | |
| WO2009034562A2 (en) | A method of assessing lung squamous cell carcinoma status in an individual | |
| AU2004270759A1 (en) | Diagnostic marker for ovarian cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |